Yazeed A. Al‐Sheikh

King Saud University

Papers

1

Total Citations

106

H-Index

1

About

Dr. Yazeed A. Al-Sheikh is a pioneering figure in nanobiotechnology and molecular diagnostics, whose work has fundamentally reshaped clinical approaches to personalized medicine. His landmark 2013 paper, "Role and implications of nanodiagnostics in the changing trends of clinical diagnosis," has garnered over 106 citations, establishing him as a key voice in the integration of nanobiotechnology with pharmacogenetics, pharmacogenomics, and pharmacoproteomics. Dr. Al-Sheikh’s major contribution lies in demonstrating how nanodiagnostics enables the precise molecular profiling necessary for developing personalized cancer therapies, moving beyond traditional diagnostics to incorporate environmental and genetic factors. His research has illuminated the critical role of nanoparticle-based platforms in early disease detection and tailored treatment strategies, bridging the gap between laboratory innovation and clinical application. Beyond his citation impact, Dr. Al-Sheikh is recognized for advancing the conceptual framework that links nanoscale tools with real-world diagnostic challenges, making him an influential mentor and thought leader. His work continues to inspire researchers exploring the intersection of nanotechnology and precision medicine, offering a roadmap for more effective, individualized patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
106
Total Citations
106
Avg Citations/Paper
🏆 Most Cited Paper
Role and implications of nanodiagnostics in the changing trends of clinical diagnosis
106 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: King Saud University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago